Giustina, Andrea
Giustina, Andrea
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response
2021 Chiloiro, S; Giampietro, A; Mirra, F; Donfrancesco, F; Tartaglione, T; Mattogno, Pp; Angelini, Flavia; Lauretti, Liverana; Gessi, M; Anile, Carmelo; Rindi, G; Giustina, A; Fleseriu, M; Pontecorvi, A; De Marinis Grasso, Laura; Bianchi, A.
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs.
2020 Chiloiro, S; Giampietro, A; Frara, S; Bima, C; Donfrancesco, F; Fleseriu, Cm; Pontecorvi, A; Giustina, A; Fleseriu, M; De Marinis Grasso, Laura; Bianchi, A.
The Changing Clinical Spectrum of Hypophysitis
2019 Chiloiro, S.; Capoluongo, E. D.; Tartaglione, T.; Giampietro, A.; Bianchi, A.; Giustina, A.; Pontecorvi, A.; De Marinis, L.
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.
2018 Chiloiro, S; Mazziotti, G; Giampietro, A; Bianchi, A; Frara, S; Mormando, M; Pontecorvi, A; Giustina, A; De Marinis Grasso, Laura
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment.
2018 Chiloiro, S; Mormando, M; Bianchi, A; Giampietro, A; Milardi, D; Bima, C; Grande, G; Formenti, Am; Mazziotti, G; Pontecorvi, A; Giustina, A; De Marinis Grasso, Laura
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients.
2016 Mormando, M; Chiloiro, S; Bianchi, A; Giampietro, A; Angelini, F; Tartaglione, L; Nasto, L; Milardi, D; Formenti, Am; Giustina, A; De Marinis Grasso, Laura
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2021 | Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response | Chiloiro, S; Giampietro, A; Mirra, F; Donfrancesco, F; Tartaglione, T; Mattogno, Pp; Angelini, Flavia; Lauretti, Liverana; Gessi, M; Anile, Carmelo; Rindi, G; Giustina, A; Fleseriu, M; Pontecorvi, A; De Marinis Grasso, Laura; Bianchi, A. | |
| 1-gen-2020 | Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. | Chiloiro, S; Giampietro, A; Frara, S; Bima, C; Donfrancesco, F; Fleseriu, Cm; Pontecorvi, A; Giustina, A; Fleseriu, M; De Marinis Grasso, Laura; Bianchi, A. | |
| 1-gen-2019 | The Changing Clinical Spectrum of Hypophysitis | Chiloiro, S.; Capoluongo, E. D.; Tartaglione, T.; Giampietro, A.; Bianchi, A.; Giustina, A.; Pontecorvi, A.; De Marinis, L. | |
| 1-gen-2018 | Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. | Chiloiro, S; Mazziotti, G; Giampietro, A; Bianchi, A; Frara, S; Mormando, M; Pontecorvi, A; Giustina, A; De Marinis Grasso, Laura | |
| 1-gen-2018 | Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. | Chiloiro, S; Mormando, M; Bianchi, A; Giampietro, A; Milardi, D; Bima, C; Grande, G; Formenti, Am; Mazziotti, G; Pontecorvi, A; Giustina, A; De Marinis Grasso, Laura | |
| 1-gen-2016 | Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. | Mormando, M; Chiloiro, S; Bianchi, A; Giampietro, A; Angelini, F; Tartaglione, L; Nasto, L; Milardi, D; Formenti, Am; Giustina, A; De Marinis Grasso, Laura |